Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology News Central (ONC)
“Emerging data from this confirmatory study have highlighted a safety profile that is unfavorable compared to that previously observed in clinical evaluation.” — Christelle Huguet, PhD, Ipsen
Hematology/Oncology March 17th 2026
Therapeutic Advances in Musculoskeletal Disease
Early treatment phases may transiently promote immune activation, whereas sustained therapy, by reducing BMI and lowering systemic inflammation, may mitigate this effect.
Cardiology March 13th 2026
Psychiatrist.com
TikTok claims its team of 40,000 safety professionals works to remove violations of their Community Guidelines while encouraging the community to report any content or accounts they’re concerned about.
Emergency Medicine March 12th 2026
Epoch Health
“Use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.” — FDA Class II Recall Definition
Cardiology March 10th 2026
Annals of Internal Medicine
The primary study outcome was a composite of serious bleeding events leading to hospitalization. Secondary study outcomes included composites of stroke or systemic embolism.
The American Journal of Nursing (AJN)
Patients seeking ketamine treatment have often spent years seeking to treat their mental health symptoms, and out of that desperation, seek out care without thoroughly vetting their options or practitioners.
Community/Public Health Nursing February 26th 2026